Induced and spontaneous diabetes mellitus and suppression of cell mediated immunologic responses. Granuloma formation, delayed dermal reactivity, and allograft rejection

Abstract

These investigations delineate the recently described suppression of a form of cellular hypersensitivity in mice with streptozotocin induced diabetes mellitus using a variety of cell mediated immunologic responses in animals with several different forms of diabetes. Streptozotocin and alloxan induced diabetic mice and db/db genetically determined diabetic mice showed reductions in the areas of inflammation around Schistosoma mansoni eggs injected into the pulmonary vasculature of 68, 70, 77% respectively. In contrast, streptozotocin induced diabetes had no effect on the nonimmunologic foreign body granuloma around divinyl benzene copolymer beads injected into the pulmonary arterioles. Animals protected from diabetes by treatment with nicotinamide before streptozotocin administration did not develop hyperglycemia and had normal areas of immunologic granuloma formation around schistosome eggs. Treatment with insulin reversed the suppression of schistosome egg granuloma formation in both streptozotocin and alloxan diabetic animals. Two additional in vivo parameters of cellular immunologic reactivity were examined in streptozotocin induced diabetes: delayed footpad swelling was essentially eliminated; skin graft survival across the H 2 area was significantly prolonged from 10.2 days in the controls to 14.4 days in moderately diabetic A/J mice. These observations suggest that diabetes mellitus is associated with suppression of cell mediated reactions in vivo and that the defect is reversible with insulin treatment.